Objective: To evaluate the efficacy of midazolam and propofol for postoperative sedation and early extubation following cardiac surgery. Methods: This randomized control trial was conducted at the Cardiac Surgery Department of the Choudhary Pervaiz Elahi Institute of Cardiology from February 2019 to February 2020. A total of 60 American Society of Anesthesiologists (ASA) III patients planned to undergo coronary artery bypass graft surgery were included. After shifting into intensive care unit (ICU), patients were divided in two groups by lottery method and study drugs propofol and midazolam were started. Both infusions were terminated after four hours and patients were assessed for postoperative sedation and extubation. Hemodynamic parameters, arterial blood gases and respiratory functions were assessed and recorded. Results: The mean time to awakening, time to extubation in midazolam group was 94.11±4.36 minutes, 94.47±6.11 minutes respectively and in propofol group it was 96.58±4.31 minutes, 91.91±3.94 minutes respectively. Difference was statistically significant. Conclusion: Results of our study reveal that there was no difference in both drugs regarding sedation and extubation time, both drugs are safe, effective and useful in patients of coronary artery bypass graft surgery. Keywords: Coronary artery bypass graft, Midazolam, Propofol, Extubation, Sedation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.